Answers are grounded in this paper and cite their sources.
Mendelian randomization reveals links between blood metabolites and glioblastoma risk, suggesting protective roles of phospholipid and tryptophan pathways.
This study represents the first large-scale Mendelian randomization analysis to establish causal relationships between multiple blood metabolites and glioblastoma risk, particularly identifying protective factors within phospholipid and tryptophan metabolic pathways.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: